SPONSOR
3D Medicines (Sichuan) Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
NCT06123754 Phase 3
Recruiting
Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Non-small Cell Lung Cancer
NCT05112991 Phase 2
Recruiting
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Advanced Endometrial Cancer